Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vehicle | Placebo Comparator | Vehicle (placebo) treatment, twice a week for four weeks. |
|
| Test Product 10156 | Experimental | Product 10156 treatment, twice a week for four weeks. |
|
| Test Product 49778 | Experimental | Product 49778 treatment, twice a week for four weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Test Product 49778 | Drug |
| ||
| Test Product 10156 |
| Measure | Description | Time Frame |
|---|---|---|
| Symptom Improvement (investigator assessment) | Proportion of subjects with a response of clear or almost clear, and at least a two-grade improvement from baseline to week 4 | Week 4 |
| Measure | Description | Time Frame |
|---|---|---|
| Symptom Improvement (subject assessment) | Assess the change in the pruritus score from baseline to week 2 and to week 4. | Weeks 2 and 4 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ira Lawrence, MD | Medicis Pharmaceutical | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fremont | California | United States | ||||
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Vehicle (placebo) | Drug |
|
| Los Angeles |
| California |
| United States |
| San Diego | California | United States |
| New Haven | Connecticut | United States |
| Aventura | Florida | United States |
| Augusta | Georgia | United States |
| Snellville | Georgia | United States |
| Evansville | Indiana | United States |
| Detroit | Michigan | United States |
| Fridley | Minnesota | United States |
| Paramus | New Jersey | United States |
| Mount Kisco | New York | United States |
| New York | New York | United States |
| High Point | North Carolina | United States |
| Portland | Oregon | United States |
| Philadelphia | Pennsylvania | United States |
| Arlington | Texas | United States |
| Austin | Texas | United States |
| College Station | Texas | United States |
| Plano | Texas | United States |
| Webster | Texas | United States |
| Salt Lake City | Utah | United States |
| ID | Term |
|---|---|
| D012628 | Dermatitis, Seborrheic |
| ID | Term |
|---|---|
| D003872 | Dermatitis |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012625 | Sebaceous Gland Diseases |
| D017443 | Skin Diseases, Eczematous |
| D017444 | Skin Diseases, Papulosquamous |
Not provided
Not provided